2/25
04:10 pm
iinn
Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Low
Report
Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
2/18
08:32 am
iinn
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
Low
Report
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
2/17
08:00 am
iinn
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
Low
Report
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
2/12
04:01 pm
iinn
Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
Low
Report
Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
2/9
07:00 am
iinn
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
High
Report
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
2/5
08:00 am
iinn
Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
Medium
Report
Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
2/3
09:22 am
iinn
Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market
Low
Report
Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market
1/29
08:30 am
iinn
ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center
Low
Report
ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center
3/5
04:05 pm
iinn
Form SCHEDULE 13G/A Inspira Technologies Filed by: Ben-Noon Dagi Shahar
Low
Report
Form SCHEDULE 13G/A Inspira Technologies Filed by: Ben-Noon Dagi Shahar
2/25
04:01 pm
iinn
Form 6-K Inspira Technologies For: Feb 25
Low
Report
Form 6-K Inspira Technologies For: Feb 25
2/18
08:31 am
iinn
Form 6-K Inspira Technologies For: Feb 18
Low
Report
Form 6-K Inspira Technologies For: Feb 18
2/18
06:00 am
iinn
Form 6-K Inspira Technologies For: Feb 17
Low
Report
Form 6-K Inspira Technologies For: Feb 17
2/17
05:30 pm
iinn
Form 424B5 Inspira Technologies
Low
Report
Form 424B5 Inspira Technologies
2/17
04:34 pm
iinn
Form SCHEDULE 13G/A Inspira Technologies Filed by: Hayon Joe Ronen
Low
Report
Form SCHEDULE 13G/A Inspira Technologies Filed by: Hayon Joe Ronen
2/17
08:21 am
iinn
Form SCHEDULE 13G/A Inspira Technologies Filed by: Hayon Joe Ronen
Low
Report
Form SCHEDULE 13G/A Inspira Technologies Filed by: Hayon Joe Ronen
2/12
04:01 pm
iinn
Form 6-K Inspira Technologies For: Feb 12
Low
Report
Form 6-K Inspira Technologies For: Feb 12
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register